BTC Digital Regains Nasdaq Compliance
BTC Digital Ltd. ("BTC Digital" or the "Company") (NASDAQ:BTCT), a Nasdaq-listed digital computing infrastructure company, today announced that it has received written notification from the Listing
Stocks · News reference
Nasdaq Falls Over 200 Points; US Goods Trade Gap Widens In May
US stocks traded lower, Nasdaq fell 200 pts, Dow down 0.31%, S&P 500 dropped 0.50%. Health care shares rose 2.1%, tech stocks fell 1.8%.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Shares of crypto-related companies are trading lower amid a decline in Bitcoin prices following August's hotter-than-expected payrolls report, which boosted expectations for a potential Federal Reserve rate hike at its next meeting. A stronger U.S. dollar and higher interest-rate expectations are further weighing on crypto and other risk assets by reducing investor appetite for speculative investments.
Shares of crypto-linked stocks are trading higher as Bitcoin prices hit $80,000 amid lower yields and a weaker dollar. Fed's Waller's comments that he is inclined to support holding interest rates steady may have further supported the speculative asset by easing concerns about tighter monetary policy and improving risk appetite.
Shares of crypto-linked stocks are trading lower amid a decline in Bitcoin after climbing bond yields and August's economic data raised inflation concerns and interest-rate hike expectations. Rising rates can pressure risk assets as investors become more cautious and shift toward safer investments.
8-K filing — CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
Filed: 2026-08-31 AccNo: 0001477932-26-005329 Size: 947 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits
Creative Medical shares are trading higher after the company announced that all patients have now been enrolled and treated across its FDA-cleared ADAPT clinical trial of CELZ-201 / Olastrocel, including the opioid expansion cohort.